| [1] |
Tatemoto K,Hosoya M,Habata Y, et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun, 1998, 251(2): 471-476.
|
| [2] |
Habata Y,Fujii R,Hosoya M, et al.Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum[J]. Biochim Biophys Acta, 1999, 1452(1): 25-35.
|
| [3] |
Lee DK,Cheng R,Nguyen T, et al.Characterization of Apelin, the ligand for the APJ receptor[J]. J Neurochem, 2000, 74(1): 34-41.
|
| [4] |
Chapman NA,Dupré DJ,Rainey JK.The apelin receptor：physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR[J]. Biochem Cell Biol, 2014, 92(6): 431-440.
|
| [5] |
Chaves-Almagro C,Castan-Laurell I,Dray C, et al.Apelin receptors：From signaling to antidiabetic strategy[J]. Eur J Pharmacol, 2015, 763(PtB): 149-159.
|
| [6] |
Malkani N,Biggar K,Shehab MA, et al.Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC[J]. Mol Cell Endocrinol, 2016(425): 48-60.
|
| [7] |
Sanz-Clemente A,Matta JA,Isaac JT, et al.Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors[J]. Neuron, 2010, 67(6): 984-996.
|
| [8] |
刘廪,朱颖军,张伟, 等. 鞘内注射NR2B9c缓解大鼠神经痛理性疼痛[J]. 中华行为医学与脑科学杂志, 2014, 23(9): 784-785.
|
| [9] |
张敬美,白波,张秋玲, 等. 大鼠尾核内Apelin的痛觉调制作用及其机制的实验研究[J]. 中华行为医学与脑科学杂志, 2010, 19(2): 97-100.
|
| [10] |
Xu N,Wang H,Fan L, et al.Supraspinal administration of apelin-13 induces antinociception via the opioid receptor in mice[J]. Peptides, 2009, 30(6): 1153-1157.
|
| [11] |
Lv SY,Qin YJ,Wang NB, et al.Supraspinal antinociceptive effect of apelin-13 in a mouse visceral pain model[J]. Peptides, 2012, 37(1): 165-170.
|
| [12] |
Lv Su,Yang YJ,Hong S, et al.Intrathecal apelin-13 produced different actions in formalin test and tail-flick test in mice[J]. Protein Pept Lett, 2013, 20(8): 926-931.
|
| [13] |
Wang J,Feng C,He Y, et al.Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis[J]. Oncotarget, 2015, 6(29): 27700-27713.
|
| [14] |
Pechkova E,Bragazzi NL,Fiordoro S, et al.Langmuir-Blodgett (LB)-based nanobiocrystallography at the frontiers of cancer proteomics[J]. Anticancer Res, 2015, 35(2): 827-834.
|
| [15] |
Chen SR,Zhou HY,Byun HS, et al.Casein kinase II regulates N-methyl-D-aspartate receptor activity in spinal cords and pain hypersensitivity induced by nerve injury[J]. J Pharmacol Exp Ther, 2014, 350(2): 301-312.
|
| [16] |
Pachuau J,Li DP,Chen SR, et al.Protein kinase CK2 contributes to diminished small conductance Ca2＋-activated K＋ channel activity of hypothalamic pre-sympathetic neurons in hypertension[J]. J Neurochem, 2014, 130(5): 657-667.
|
| [17] |
Hu YM,Chen SR,Chen H, et al.Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor[J]. J Pharmacol Exp Ther, 2014, 349(2): 239-247.
|
| [18] |
Pierre F,O'Brien SE,Haddach M, et al.Novel potent pyrimido[4, 5-c]quinoline inhibitors of protein kinase CK2：SAR and preliminary assessment of their analgesic and anti-viral properties[J]. Bioorg Med Chem Lett, 2011, 21(6): 1687-1691.
|
| [19] |
Cook DR,Gleichman AJ,Cross SA, et al.NMDA receptor modulation by the neuropeptide apelin：implications for excitotoxic injury[J]. J Neurochem, 2011, 118(6): 1113-1123.
|